Glenmark Pharma gains on reporting consolidated net profit of Rs 171.48 crore in Q4

16 May 2016 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 875.40, up by 6.65 points or 0.77% from its previous closing of Rs. 868.75 on the BSE.

The scrip opened at Rs. 874.95 and has touched a high and low of Rs. 880.50 and Rs. 872.80 respectively. So far 9099 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1261.95 on 21-Aug-2015 and a 52 week low of Rs. 671.50 on 12-Feb-2016.

Last one week high and low of the scrip stood at Rs. 884.50 and Rs. 816.00 respectively. The current market cap of the company is Rs. 24716.34 crore.

The promoters holding in the company stood at 46.48% while Institutions and Non-Institutions held 41.92% and 11.60% respectively.

Glenmark Pharmaceuticals has posted a fall of 24.27% in its net profit at Rs 507.75 crore for the quarter ended March 31, 2016 as compared to Rs 670.43 crore for the same quarter in the previous year. Total income of the company has decreased by 37.53% at Rs 1972.67 crore for quarter under review as compared to Rs 3157.79 crore for the quarter ended March 31, 2015.

On consolidated basis, the company has posted a net profit after taxes, minority interest and share of profit of associates of Rs 171.48 crore for the quarter ended March 31, 2016. Total income of the company stood at Rs 2292.94 crore for the quarter ended March 31, 2016.

For the year ended March 31, 2016, the company has posted a rise of 45.75% in its net profit at Rs 1468.43 crore as compared to Rs 1007.52 crore for the same period in the previous year. Total income of company increased by 20.51% at Rs 6230.78 crore for year under review as compared to Rs 5170.54 crore for the period ended March 31, 2015.  

For the year ended March 31, 2016, on the consolidated basis, the company has posted a net profit after taxes, minority interest and share of profit of associates of Rs 720.10 crore. Total income of the company stood at Rs 7579.99 crore for the year ended March 31, 2016. 

Glenmark Pharma Share Price

2013.25 -22.65 (-1.11%)
01-Jan-2026 14:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.65
Dr. Reddys Lab 1250.90
Cipla 1499.55
Zydus Lifesciences 913.30
Lupin 2099.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×